ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,000 | +900.0% | 75,543 | +5857.6% | 0.00% | – |
| Q2 2023 | $1,000 | – | 1,268 | +85.1% | 0.00% | – |
| Q1 2023 | $0 | – | 685 | +123.1% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 307 | -98.3% | 0.00% | – |
| Q3 2022 | $31,000 | +210.0% | 17,999 | +110.5% | 0.00% | – |
| Q2 2022 | $10,000 | -23.1% | 8,551 | -59.5% | 0.00% | – |
| Q1 2022 | $13,000 | -76.8% | 21,090 | -58.7% | 0.00% | – |
| Q4 2021 | $56,000 | +16.7% | 51,032 | +93.7% | 0.00% | – |
| Q3 2021 | $48,000 | -20.0% | 26,343 | +16.7% | 0.00% | – |
| Q2 2021 | $60,000 | -25.0% | 22,564 | +2.3% | 0.00% | – |
| Q1 2021 | $80,000 | +110.5% | 22,063 | +46.6% | 0.00% | – |
| Q4 2020 | $38,000 | -5.0% | 15,051 | -4.3% | 0.00% | – |
| Q3 2020 | $40,000 | -24.5% | 15,735 | -1.6% | 0.00% | – |
| Q2 2020 | $53,000 | +55.9% | 15,994 | +14.8% | 0.00% | – |
| Q1 2020 | $34,000 | -5.6% | 13,927 | +83.9% | 0.00% | – |
| Q4 2019 | $36,000 | -60.0% | 7,574 | -64.0% | 0.00% | – |
| Q3 2019 | $90,000 | -50.5% | 21,035 | -32.4% | 0.00% | – |
| Q2 2019 | $182,000 | +106.8% | 31,125 | +36.6% | 0.00% | – |
| Q1 2019 | $88,000 | +166.7% | 22,785 | +28.1% | 0.00% | – |
| Q4 2018 | $33,000 | -70.8% | 17,785 | -49.4% | 0.00% | – |
| Q3 2018 | $113,000 | +36.1% | 35,142 | +28.1% | 0.00% | – |
| Q2 2018 | $83,000 | -17.8% | 27,436 | +6.0% | 0.00% | – |
| Q1 2018 | $101,000 | -3.8% | 25,876 | +2.5% | 0.00% | – |
| Q4 2017 | $105,000 | -50.9% | 25,244 | -27.6% | 0.00% | – |
| Q3 2017 | $214,000 | +45.6% | 34,874 | +48.2% | 0.00% | – |
| Q2 2017 | $147,000 | -13.5% | 23,537 | -12.0% | 0.00% | – |
| Q1 2017 | $170,000 | -17.5% | 26,756 | -30.4% | 0.00% | – |
| Q4 2016 | $206,000 | +44.1% | 38,458 | +52.2% | 0.00% | – |
| Q3 2016 | $143,000 | +36.2% | 25,273 | +31.4% | 0.00% | – |
| Q2 2016 | $105,000 | -12.5% | 19,235 | +18.8% | 0.00% | – |
| Q1 2016 | $120,000 | -10.4% | 16,189 | -0.2% | 0.00% | – |
| Q4 2015 | $134,000 | -6.3% | 16,215 | +1.9% | 0.00% | – |
| Q3 2015 | $143,000 | +429.6% | 15,915 | +611.1% | 0.00% | – |
| Q2 2015 | $27,000 | -61.4% | 2,238 | -65.6% | 0.00% | – |
| Q1 2015 | $70,000 | +204.3% | 6,500 | +44.4% | 0.00% | – |
| Q4 2014 | $23,000 | +360.0% | 4,500 | +125.0% | 0.00% | – |
| Q3 2014 | $5,000 | -72.2% | 2,000 | -55.6% | 0.00% | – |
| Q2 2014 | $18,000 | -84.3% | 4,500 | -82.1% | 0.00% | – |
| Q1 2014 | $115,000 | +12.7% | 25,191 | +7.2% | 0.00% | – |
| Q4 2013 | $102,000 | +1.0% | 23,500 | -7.6% | 0.00% | – |
| Q3 2013 | $101,000 | +90.6% | 25,438 | +1.8% | 0.00% | – |
| Q2 2013 | $53,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |